Cargando…
Sarcoma Common MHC-I Haplotype Restricts Tumor-Specific CD8+ T Cell Response
SIMPLE SUMMARY: Immunotherapy targeting immune checkpoint pathways have recently attracted great attention in cancer treatment, but better strategies are needed to identify patients likely to benefit from it. The major histocompatibility complex (MHC) class I expression in cancer cells greatly influ...
Autores principales: | Mosca, Laura, de Angelis, Alessandra, Ronchi, Andrea, De Chiara, Annarosaria, Fazioli, Flavio, Ruosi, Carlo, Altucci, Lucia, Conte, Mariarosaria, de Nigris, Filomena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322060/ https://www.ncbi.nlm.nih.gov/pubmed/35884474 http://dx.doi.org/10.3390/cancers14143414 |
Ejemplares similares
-
Sarcoma Spheroids and Organoids—Promising Tools in the Era of Personalized Medicine
por: Colella, Gianluca, et al.
Publicado: (2018) -
Post-surgery fluids promote transition of cancer stem cell-to-endothelial and AKT/mTOR activity, contributing to relapse of giant cell tumors of bone
por: Fazioli, Flavio, et al.
Publicado: (2017) -
Ex Vivo Behaviour of Human Bone Tumor Endothelial Cells
por: Infante, Teresa, et al.
Publicado: (2013) -
Lysosome purinergic receptor P2X4 regulates neoangiogenesis induced by microvesicles from sarcoma patients
por: Palinski, Wulf, et al.
Publicado: (2021) -
Patient-derived organoids as a potential model to predict response to PD-1/PD-L1 checkpoint inhibitors
por: Scognamiglio, Giosue, et al.
Publicado: (2019)